1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)
Open Access
- 18 July 2019
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 9 (7) , 146
Abstract
The trithiolato bridged diruthenium complex DiRu-1 [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ is highly cytotoxic against various cancer cell lines, but its exact mode of action remains unknown. The present 1H HR-MAS NMR-based metabolomic study was performed on ovarian cancer cell line A2780, on its cis-Pt resistant variant A2780cisR, and on the cell line HEK-293 treated with 0.03 µM and 0.015 µM of DiRu-1 corresponding to full and half IC50 doses, respectively, to investigate the mode of action of this ruthenium complex. The resulting changes in the metabolic profile of the cell lines were studied using HR-MAS NMR of cell lysates and a subsequent statistical analysis. We show that DiRu-1 in a 0.03 µM dose has significant impact on the levels of a number of metabolites, such as glutamine, glutamate, glutathione, cysteine, lipid, creatine, lactate, and acetate, especially pronounced in the A2780cisR cell line. The IC50/2 dose shows some significant changes, but full IC50 appears to be necessary to observe the full effect. Overall, the metabolic changes observed suggest that redox homeostasis, the Warburg effect, and the lipid metabolism are affected by DiRu-1.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (206021-128736)
This publication has 48 references indexed in Scilit:
- Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancerCancer Letters, 2017
- Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell GrowthCell Metabolism, 2016
- Insights into the in vitro Anticancer Effects of Diruthenium‐1ChemMedChem, 2016
- Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literatureMetabolomics, 2016
- Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugsCoordination Chemistry Reviews, 2016
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Glutathione synthesisBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potentialJBIC Journal of Biological Inorganic Chemistry, 2012
- A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapyAmino Acids, 2011
- Creatine as an antioxidantAmino Acids, 2011